Suppr超能文献

血管移植物感染手术治疗后的远期结果

Late results following surgical management of vascular graft infection.

作者信息

Reilly L M, Altman H, Lusby R J, Kersh R A, Ehrenfeld W K, Stoney R J

出版信息

J Vasc Surg. 1984 Jan;1(1):36-44.

PMID:6481870
Abstract

Ninety-two patients underwent surgical treatment for 59 prosthetic graft infections and 33 secondary aortoenteric fistulas. Definitive treatment was accomplished with a low perioperative mortality rate (14%). Long-term follow-up confirmed that most patients were cured of their infection or fistula, and 88% of the patients who survived the perioperative period (67 of 76) had no further evidence of infection when followed up from 10 months to 12 1/2 years postoperatively. The 12% late mortality rate (9 of 76) was secondary to persistent infection and aortic stump disruption. When perioperative and late deaths in both groups are combined, 67 of 92 patients (73%) were cured of their prosthetic graft infection. Factors associated with a favorable prognosis for survival and cure of infection were autogenous reconstruction and possibly staged operative repair. Poor prognosis for survival and cure of infection resulted from aortic stump disruption, persistent infection, and retained graft material. Significant morbidity (amputation and multiple operative procedures) was related to the severity of underlying vascular disease, the inadequacy of extra-anatomic reconstruction, and in some cases progression of vascular disease. The major challenges in the treatment of graft infection at present are the preoperative identification of limited graft infection and the successful management of the interrupted aorta. Complex and innovative reconstructive procedures continue to be necessary to ensure limb salvage and remain a considerable technical challenge. Nonetheless, the prospects for cure as reported in this series justify an aggressive operative approach. A successful outcome following definitive treatment of these devastating complications is possible for the majority of affected patients.

摘要

92例患者因59例人工血管移植物感染和33例继发性主动脉肠瘘接受了手术治疗。最终治疗取得了较低的围手术期死亡率(14%)。长期随访证实,大多数患者的感染或瘘得到治愈,围手术期存活的患者中88%(76例中的67例)在术后10个月至12年半的随访中无感染复发迹象。12%的晚期死亡率(76例中的9例)是由持续感染和主动脉残端破裂所致。若将两组的围手术期死亡和晚期死亡合并计算,92例患者中有67例(73%)的人工血管移植物感染得到治愈。与生存及感染治愈预后良好相关的因素是自体血管重建,可能还有分期手术修复。生存及感染治愈预后不良是由主动脉残端破裂、持续感染和移植物材料残留所致。严重的并发症(截肢和多次手术)与潜在血管疾病的严重程度、解剖外重建不充分以及某些情况下血管疾病的进展有关。目前移植物感染治疗中的主要挑战是术前识别局限性移植物感染以及成功处理中断的主动脉。为确保肢体保全,复杂且创新的重建手术仍然必不可少,并且仍然是一项重大的技术挑战。尽管如此,本系列报道的治愈前景证明积极的手术方法是合理的。对于大多数受影响的患者而言,对这些毁灭性并发症进行最终治疗后取得成功的结果是可能的。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验